SITM$728.56+2.4%Cap: $19.2BP/E: —52w: [========|--](May 24)
Setup
SiTime makes MEMS oscillators — the precision timing layer embedded in AI datacenter servers, 800G/1.6T optical transceivers, and networking switches. A four-filing cluster in May 2026 (Q1 earnings May 6, HSR clearance May 11, Renesas historical financials May 19, $1.35B convertible close May 22) produced specific facts that alter both the deal accretion model and the regulatory risk framing. Forward P/E 68x.
What the Filings Say
Q1 2026 (8-K May 6): Revenue $113.6M (+88.3% YoY). Non-GAAP gross margin 64.5% — 250bps above Q1 guidance of 62% and above the stated ceiling of the 60-65% long-term target range. CED (AI/datacenter) segment: seventh consecutive quarter above 100% YoY growth. Non-GAAP EPS $1.44 vs $1.16 consensus. Four consecutive beats averaging +35%.
Renesas Timing historical financials (8-K May 19, audited PwC Japan): FY2025 revenue $207.7M (+3.1% YoY). Q1 2026 unaudited: $69.3M, +47.4% YoY from $47.0M in Q1 2025 — annualizing to ≈$277M and accelerating. Gross margin (cost of sales only, ex-amortization): $157.2M / $207.7M = 75.7%. Note: the "revenue less direct expenses" figure of $76.2M (≈58.6%) that has circulated is an operating-level metric — it deducts R&D ($29.3M) and SG&A ($6.1M). Gross margin is 75.7%.
HSR clearance (8-K May 11): Waiting period expired May 8, satisfying Section 8.1(a) of the Asset Purchase Agreement — the regulatory conditions precedent. Target entity is Renesas Electronics America Inc., a California corporation. CFIUS is structurally inapplicable to U.S.-entity acquisitions. No foreign regulatory approvals listed as outstanding conditions. Remaining: standard reps/warranties and covenant compliance.
$1.35B 0% Convertible Notes (8-K May 22): Launched $1.1B, upsized to $1.2B at pricing, greenshoe ($150M) fully exercised May 20. Final size $1.35B. Conversion price $1,040.47/share (50% premium). Capped call ($121.5M) limits dilution up to $1,734/share. Zero coupon — no cash interest drag. Bridge loan superseded. Net proceeds ≈$1.20B after capped call cost, designated to fund the Renesas cash consideration.
What the Market Thinks
Nine analysts, 100% bullish, mean target $827.78 (range $750-900). Q2 2026 consensus EPS $1.96 — implying GM guidance of ≈62% again, consistent with sell-side models anchored to the stated 60-65% long-term target. ATM IV 80.3% vs 30-day realized vol 94.6% — options are cheap relative to recent moves. August expiry (88 days, brackets Q2 earnings Aug 5) prices IV at 89.3%, implying ±22% earnings move. Max pain $700. P/C OI ratio 0.25 — call-heavy positioning.
Probability-weighted 12-month target (five scenarios, described below): $630. At current prices, forward EV is approximately -14%.
Why the Gap Exists
1. Renesas Timing was framed as a divestiture of non-core assets. Default analyst assumption: flat-to-modestly-declining revenue from an asset a large company was shedding. Audited Q1 2026 shows +47% YoY. If sell-side models $240-250M annualized and the actual run rate approaches $300M at close, that is ≈$45-60M revenue upside on the deal — carrying ≈$34-45M incremental annual gross profit at 75.7% GM that is not in consensus models.
2. Combined GM will exceed the stated 60-65% target. SITM standalone is already at 64.5% — above the ceiling — before Renesas Timing's higher-margin assets arrive. Blended math: ≈$510M SITM at ≈65% + ≈$295M Renesas Timing at ≈75.7% = ≈$805M combined at ≈69% blended GM. Models anchored to management's 60-65% guidance are approximately 500bps below where the blended entity will operate.
3. SITM is growing 3x faster than peers in identical demand. Skyworks reported AI datacenter timing growing "nearly 50% year" (Q2 FY2026, May 5). MCHP (quartz incumbent) is in recovery with no comparable AI timing breakout. SITM CED grew 158% YoY in the same period. That 3x differential — in the same hyperscaler capex environment — is technology displacement: MEMS timing is technically disqualifying quartz at 1.6T jitter specifications, not competing with it.
Risks
1. Valuation asymmetry is the primary risk. At 68x forward P/E, the bull case is capped (+20% if everything executes) and the bear cases are severe (-31% to -71% on miss or macro). Beta 2.91 means 31.5% of variance is systematic with no offsetting edge. Probability-weighted EV at current prices is negative.
2. MegaChips $311.8M strategic sale (May 14, unexplained). MegaChips is a strategic partner — not a passive financial holder. They sold 400,000 shares at ≈$779.50, two days after Director Akira Takata sold 1,500 shares. No 8-K filed explaining the basis. Stock has pulled back 6.5% from their exit. Zero officer open-market purchases in 2026 against ≈$320M in combined strategic and officer selling. The complete absence of any buying is the single largest unresolved bearish signal.
3. Integration execution. 160 engineers, product overlap between SITM MEMS and Renesas crystal oscillators, cross-cultural U.S./Japan integration. First quarter of combined results will show whether the 75.7% GM is achievable at scale.
4. Inventory cycle exposure. Finished goods inventory +42% at year-end 2025. If optical module customers build inventory ahead of rack deployments, 1-2 quarters of order softening are possible independent of underlying demand.
Catalysts
- August 5, 2026 — Q2 2026 earnings. Options market pricing ±22% move. If non-GAAP GM ≥ 65%, estimate revisions on combined GM become unavoidable. If GM reverts to 62-63%, the ceiling-break thesis weakens.
- Q3-Q4 2026 — Deal close + first combined company guidance. Revenue run rate and blended GM statement will confirm or refute the ≈$40M GP estimate gap. The single largest catalyst in the thesis.
- Ongoing — MegaChips sale explanation. Any 8-K disclosing a deal-required basis removes the informed-seller overhang.
What Would Change Our Mind
Bear: Q2 non-GAAP GM prints below 63% without a product-transition explanation; CED YoY growth falls below 80%; any 8-K extending the expected deal close timeline; Renesas Timing engineers depart post-close (Item 5.02 filing).
Bull: MegaChips sale confirmed deal-required in a filing; first combined quarter revenue guidance ≥ $185M at GM ≥ 66%; officer open-market purchase (Form 4 code P) above $700; management explicitly attributes incremental revenue to inference rack timing content with supporting data.
Evidence
| Evidence | Source | Credibility | LR |
|---|---|---|---|
| Q1 non-GAAP GM 64.5% vs 62% guided; above 60-65% long-term target ceiling | 8-K 2026-05-06, Q1 2026 earnings press release | 0.95 | 2.0 |
| Renesas Timing Q1 2026 revenue $69.3M, +47.4% YoY (unaudited); FY2025 $207.7M audited | 8-K 2026-05-19, EX-99.1 PwC Japan audit, EX-99.2 Q1 interim | 0.97 | 2.0 |
| Renesas Timing gross margin (cost of sales ex-amortization) 75.7% — operating margin 58.6% is not GM | 8-K 2026-05-19, EX-99.1 audited financials | 0.97 | 2.0 |
| HSR cleared May 8; target is U.S. entity; CFIUS structurally inapplicable; no foreign conditions outstanding | 8-K 2026-05-11, Item 8.01 | 0.97 | 3.0 |
| $1.35B 0% converts closed, upsized twice, greenshoe exercised; bridge superseded | 8-K 2026-05-22, Item 1.01/2.03/8.01 | 0.97 | 2.0 |
| SITM CED +158% YoY vs SWKS datacenter timing ≈50% YoY in same demand environment | SWKS Q2 FY2026 call May 5 2026; SITM Q1 2026 results | 0.80 | 2.0 |
| COHR record $1.8B, "step function" order book, LTAs to end of decade, NVIDIA $2B equity + multi-year supply agreement | COHR Q3 FY2026 earnings call May 6 2026 | 0.80 | 1.4 |
| Hyperscalers raised/reaffirmed 2026 capex: META $125-145B, GOOG $180-190B, AMZN $225B+, MSFT sequential increase | META/GOOG/MSFT/AMZN Q1 2026 earnings calls | 0.85 | 1.3 |
| MegaChips sold 400K shares ($311.8M) May 14 at ≈$779.50; no 8-K explanation; Director Takata sold 2 days prior; zero officer open-market purchases in 2026 | Form 4 filings SEC EDGAR May 12-14 2026 | 0.95 | 0.75 |
// comments (0)